← Back to Search

Diagnostic Test

Electroanatomic Mapping for Tetralogy of Fallot

N/A
Recruiting
Led By Edward T O'Leary, MD
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights

Study Summary

This trial is looking at individuals with repaired Tetralogy of Fallot who are at risk for sudden cardiac death from ventricular tachycardia. The goal is to identify which individuals are at risk and to explore the feasibility of a new technology to help distinguish between slow conduction and conduction block.

Who is the study for?
This trial is for individuals who have had surgery to correct Tetralogy of Fallot or double outlet right ventricle and now need a procedure called TPVR because they're at risk for very fast heartbeats or sudden cardiac death. Participants must weigh at least 25 kg.Check my eligibility
What is being tested?
The study is looking into how the placement of a new valve in the heart (TPVR) might affect areas with abnormal electrical activity that could lead to dangerous heart rhythms, using advanced mapping techniques.See study design
What are the potential side effects?
While specific side effects are not listed, procedures involving the heart like TPVR can generally include risks such as bleeding, infection, arrhythmias, and damage to surrounding structures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Future arrhythmic event (composite)
Jailed anatomical isthmus area
Secondary outcome measures
Number, location, and dimensions of electroanatomically abnormal isthmuses.
Number, location, and dimensions of electroanatomically normal isthmuses.
Presence of any jailed anatomical isthmus

Trial Design

1Treatment groups
Experimental Treatment
Group I: RV mappingExperimental Treatment1 Intervention
Participants will undergo a sinus rhythm electroanatomic RV substrate map prior to TPVR.

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
763 Previous Clinical Trials
5,580,569 Total Patients Enrolled
1 Trials studying Tetralogy of Fallot
68 Patients Enrolled for Tetralogy of Fallot
AbbottIndustry Sponsor
751 Previous Clinical Trials
478,115 Total Patients Enrolled
Edward T O'Leary, MDPrincipal InvestigatorBoston Children's Hospital

Media Library

Electroanatomic substrate mapping (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05236153 — N/A
Tetralogy of Fallot Research Study Groups: RV mapping
Tetralogy of Fallot Clinical Trial 2023: Electroanatomic substrate mapping Highlights & Side Effects. Trial Name: NCT05236153 — N/A
Electroanatomic substrate mapping (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05236153 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for potential participants in this research endeavor?

"According to clinicaltrials.gov, the recruitment phase for this experiment is currently active. It was initially uploaded on September 1st 2022 and last updated on August 5th 2022."

Answered by AI

How many individuals are participating in the trial at its peak capacity?

"Affirmative. Clinicaltrials.gov records show that this medical experiment, which first appeared on September 1st 2022, is currently recruiting patients. There are 60 spots available at a single clinical site."

Answered by AI
~24 spots leftby May 2025